Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL

Clinical trial NCT00299234 · TERMINATED

Trial details

NCT number: NCT00299234
Sponsor: Monarch Medical Research
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2006-06-01
Primary completion: 2007-12-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.